Spark Investment Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-47,363
Closed -$471K 178
2020
Q1
$471K Buy
47,363
+29,441
+164% +$337K 0.25% 137
2019
Q4
$246K Sell
17,922
-12,478
-41% -$185K 0.03% 428
2019
Q3
$461K Hold
30,400
0.06% 258
2019
Q2
$598K Sell
30,400
-34,300
-53% -$569K 0.04% 355
2019
Q1
$1.07M Buy
+64,700
New +$997K 0.05% 331
2018
Q4
Sell
-16,300
Closed -$285K 735
2018
Q3
$285K Buy
16,300
+3,900
+31% +$74.8K 0.02% 528
2018
Q2
$225K Sell
12,400
-51,400
-81% -$871K 0.01% 539
2018
Q1
$1.2M Buy
+63,800
New +$1.24M 0.08% 311

Other funds holding KURA

Spark Investment Management's KURA Position: Q2 2020 in Review

Spark Investment Management sold out of Kura Oncology (KURA) in Q2 2020, closing a stake of 47,363 shares — an estimated $471K sold.

Spark Investment Management first reported a position in KURA in Q1 2018 and held it in 8 quarters. The position peaked at $1.2M in Q1 2018. 134 funds tracked by Wall St. Rank hold KURA as of Q2 2020.

  • Spark Investment Management reported no remaining Kura Oncology position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 47,363 Kura Oncology shares in Q2 2020, an estimated $471K.
  • Spark Investment Management first reported a position in Kura Oncology in Q1 2018 and held it in 8 quarters.
  • Spark Investment Management's Kura Oncology position peaked at $1.2M in Q1 2018.
  • 134 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.